Pharmacists in Westminster, MD Accepting Medicare
64 Pharmacists found. Showing 61 - 64
 Laura Winn, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Memorial Ave, Westminster, MD 21157 Phone: 410-848-3000 |
Dr. Shannon Thompson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Englar Rd, Westminster, MD 21157 Phone: 410-857-9000 |
 Dr. Joseph Okezie Ekwutife, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22 Carroll Plz, Westminster, MD 21157 Phone: 410-876-1513 Fax: 410-857-5072 |
Mr. Harry Langluttig Ii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 537 Jermor Ln, Westminster, MD 21157 Phone: 410-848-0212 |
News Archive
Obesity is an independant risk factor for prostate cancer-related death
Men who are overweight or obese when diagnosed with prostate cancer are at greater risk of death after treatment, according to a new study in the December 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Computer betting game can help predict the likelihood of opioid reuse
A computer betting game can help predict the likelihood that someone recovering from opioid addiction will reuse the pain-relieving drugs, a new study shows.
VisEn Medical introduces VivoTag 680 XL fluorescent dye for labeling biomolecules
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new VivoTag® 680 XL fluorescent dye for labeling biomolecules in a broad range of in vitro and in vivo imaging applications.
New federal funds to create first national patient registry for pulmonary fibrosis
During the 8th annual National Pulmonary Fibrosis (PF) Awareness Week, Sept. 11 to 18, the Coalition for Pulmonary Fibrosis (CPF) met with over 45 legislators, both Representatives and Senators, and as of this date there are 139 House co-sponsors for the Pulmonary Fibrosis Research Enhancement Act (PFREA) to fund research on this deadly disease.
Cedars-Sinai receives $12 million from NIH to investigate deadly lung conditions
A scientific team led by Cedars-Sinai has been awarded $12 million from the National Institutes of Health to investigate two deadly lung conditions: idiopathic pulmonary fibrosis and chronic lung allograft dysfunction.
› Verified 8 days ago
Counselors
Clinical Social Workers
Pharmacists
Dentists
Occupational Therapists
Psychologists